Anthracyclines in the treatment of early breast cancer friend or foe?
Standard chemotherapy for early breast cancer consists generally of an anthracycline – taxane - based regimen, preferably in sequence. Anthracyclines are among the most active cytotoxic drugs against breast cancer. Nevertheless, benefits attained by the use of the more potent anthracycline schedules...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2022-10-01
|
| Collection: | Breast |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S0960977622001163 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|